Shen Bo, Yu Jun, Wang Shiyan, Chu Eagle S H, Wong V W S, Zhou Xin, Lin Ge, Sung Joseph J Y, Chan Henry L Y
Institute of Digestive Disease, Department of Medicine and Therapeutics, Hong Kong, China.
Hepatology. 2008 Feb;47(2):473-83. doi: 10.1002/hep.22039.
Hepatic oxidative stress plays a critical role in metabolic forms of steatohepatitis. Phyllanthus urinaria, an herbal medicine, has been reported to have potential antioxidant properties. We tested the effects of P. urinaria on nutritional steatohepatitis both in vitro and in vivo. Immortalized normal hepatocytes (AML-12) or primary hepatocytes were exposed to control, the methionine-and-choline-deficient (MCD) culture medium, in the presence or absence of P. urinaria for 24 hours. Hepatocyte triglyceride, release of alanine aminotransferase, lipoperoxides, and reactive oxygen species production were determined. Age-matched C57BL/6 and db/db mice were fed control or MCD diet for 10 days with or without P. urinaria. Hepatic steatosis, necroinflammation, triglycerides, and lipid peroxide levels were determined. Hepatic expression of inflammatory factors and lipid regulatory mediators were assayed. P. urinaria reduced steatosis and alanine aminotransferase (ALT) levels in culture of hepatocytes in a dose-dependent manner. Phyllanthus prevented MCD-induced hepatic fat accumulation and steatohepatitis in mice. This effect was associated with repressed levels of hepatic lipid peroxides, reduced expression of cytochrome P450-2E1, pro-inflammatory tumor necrosis factor alpha, interleukin-6, dampened activation of inflammatory c-Jun N-terminal kinase (JNK) and nuclear factor kappa B (NF-kappaB), increased expression of lipolytic cytochrome P450 (Cyp4a10), and suppressed transcriptional activity of lipogenic CCAAT/enhancer binding protein beta (C/EBPbeta). Hepatic acyl co-enzyme A oxidase that regulated hepatic beta-oxidation of fatty acid and other lipid regulators were not affected by P. urinaria. In conclusion, P. urinaria effectively alleviated the steatohepatitis induced by the MCD, probably through dampening oxidative stress, ameliorating inflammation, and decreasing lipid accumulation.
肝脏氧化应激在脂肪性肝炎的代谢形式中起关键作用。草药叶下珠已被报道具有潜在的抗氧化特性。我们在体外和体内测试了叶下珠对营养性脂肪性肝炎的影响。将永生化正常肝细胞(AML-12)或原代肝细胞暴露于对照、蛋氨酸和胆碱缺乏(MCD)培养基中,在有或没有叶下珠的情况下培养24小时。测定肝细胞甘油三酯、丙氨酸转氨酶释放、脂质过氧化物和活性氧生成。将年龄匹配的C57BL/6和db/db小鼠喂食对照或MCD饮食10天,有或没有叶下珠。测定肝脏脂肪变性、坏死性炎症、甘油三酯和脂质过氧化物水平。检测炎症因子和脂质调节介质的肝脏表达。叶下珠以剂量依赖的方式降低肝细胞培养中的脂肪变性和丙氨酸转氨酶(ALT)水平。叶下珠预防了小鼠中MCD诱导的肝脏脂肪积累和脂肪性肝炎。这种作用与肝脏脂质过氧化物水平降低、细胞色素P450-2E1、促炎肿瘤坏死因子α、白细胞介素-6表达减少、炎症性c-Jun N端激酶(JNK)和核因子κB(NF-κB)激活减弱、脂解细胞色素P450(Cyp4a10)表达增加以及脂肪生成性CCAAT/增强子结合蛋白β(C/EBPβ)转录活性受抑制有关。调节肝脏脂肪酸β氧化的肝脏酰基辅酶A氧化酶和其他脂质调节因子不受叶下珠影响。总之,叶下珠可能通过减轻氧化应激、改善炎症和减少脂质积累有效缓解了MCD诱导的脂肪性肝炎。